Purdue found a fountain of new revenue last fall at Ross-Ade Stadium, after alcohol sales were expanded to the entire stadium.
St. Vincent Health will close its long-term acute hospital in Lafayette in the next two months, leaving as many as 83 workers without jobs. St. Vincent will continue to operate its other Seton Specialty Hospital in Indianapolis.
Endocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after the European Commission granted it orphan drug status.
In the last 10 years, Indiana’s major research universities—Indiana and Purdue—have nearly doubled their
science-based research budgets, to a total of $895 million. Yet Indiana’s public universities still run in the middle
of the pack nationally.
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
Purdue University will join the quest for cheap solar-generated electricity with an initiative aimed at speeding up research
across the industry. The Network for Photovoltaic Technology will launch this fall, focused on creating computer models to
eliminate costly and slow trial-and-error research in the solar industry.
Bioanalytical Systems Inc. narrowed its losses in the second fiscal quarter despite a 2 percent drop in revenue, the West
Lafayette-based contract research firm said late last week.
Toyota is halting production at six North American car-assembly plants—including Indiana facilities in Princeton and
Lafayette—beginning the week of Feb. 1 to fix gas pedals that could stick and cause acceleration without warning.